Background The preoperative differentiation of lung adenocarcinoma subtypes is critical for implementing personalized treatment but is difficult to accomplish with conventional imaging. This study aimed to develop an interpretable multimodal model integrating clinical, peritumoral, radiomic, and deep learning features to improve diagnostic accuracy. Methods A total of 3,038 patients from four hospitals were divided into training (n=1,822), test (n=608), and validation (n=608) sets. Two radiologists manually segmented two-dimensional tumor regions on computed tomography using ITK-SNAP software. After Pearson correlation analysis and least absolute shrinkage and selection operator regression, the radiomic score and deep learning score were generated. Clinical features were selected via univariate analysis, the Boruta algorithm, and recursive feature elimination (RFE). Individual logistic models were built and fused with the optimal combination selected via support vector machine-synthetic minority oversampling technique and extreme gradient boosting. Performance was evaluated in terms of the Obuchowski index, accuracy, F1-score, calibration, and decision curves, while interpretability was assessed via Shapley additive explanations (SHAP) and individual conditional expectation (ICE). Results The fused model achieved Obuchowski indices of 0.85 [95% confidence interval (CI): 0.84–0.87], 0.81 (95% CI: 0.78–0.83), and 0.79 (95% CI: 0.76–0.81) in the training, test, and validation sets, respectively outperforming the single-modality models. The F1-scores for the lepidic, acinar/papillary, and solid/micropapillary subtypes, respectively, were 0.77, 0.61, and 0.63 in the training set; 0.72, 0.57, and 0.59 in the test set; and 0.74, 0.54, and 0.52 in the validation set. Calibration and decision curve analysis confirmed the robustness and clinical utility of the model. SHAP analysis identified ResNet-101 feature as the best predictor, followed by peritumoral radiomic score, and lobulation. ICE plots revealed the linear and monotonic relationships between key features and predicted probabilities across subtypes. Conclusions The radiomics model developed in this study facilitates the accurate and interpretable preoperative classification of lung adenocarcinoma subtypes. Fusion of clinical, peritumoral, and deep learning features enhances diagnostic performance and supports clinical decision-making.
Feng-Juan Tian, Jing Ding, Zhen-Yu Cao et al.· Quantitative Imaging in Medi...· 0 citations
Objectives To develop and validate a preoperative multimodal model that predicts a high-risk recurrence phenotype indicative of poor disease-free survival (DFS), in order to stratify patients with stage IA non-small cell lung cancer (NSCLC). Materials and methods This retrospective multicenter study enrolled 342 stage IA NSCLC patients from three independent centers. The high-risk recurrence phenotype (indicative of poor DFS) was defined by postoperative pathology as the presence of spread through air spaces (STAS), lymphovascular invasion (LVI), a predominant solid/micropapillary/complex glandular pattern, or a > 5% solid/micropapillary component. Deep learning features were extracted from preoperative biopsy whole-slide images (WSI) using the UNI foundation model, and CT morphological and textural features were extracted from preoperative chest CT. An early-fusion multimodal model integrating clinical, radiomics, and pathomics features was developed and evaluated with five-fold cross-validation. The Kaplan–Meier method with log-rank tests was used to assess associations between the model-predicted risk and DFS. Logistic regression identified clinical predictors of high-risk pathology. Model interpretability and clinical utility were examined with SHapley Additive exPlanations (SHAP) and calibration analysis, respectively. Results The multimodal model achieved higher discriminative performance than each single-modality model in both the internal and external test sets. In the internal test set, it yielded an AUC of 0.76 (95% CI 0.58-0.90); in external validation, AUCs were 0.69 (95% CI 0.55-0.82) in Center 2 and 0.86 (95% CI 0.74-0.96) in Center 3. Multivariable analysis identified solid tumor density as the only independent predictor (OR = 5.13, 95% CI 1.53-17.24; P = 0.008). Model-stratified high-risk patients showed significantly inferior DFS in both the training (2-year DFS 78% vs. 99%; log-rank P < 0.0001) and external (3-year DFS 86% vs. 100%; log-rank P = 0.003) cohorts. Conclusion The multimodal model consistently predicted the high-risk recurrence phenotype across multiple centers. This phenotype may serve as a pragmatic indicator of poor DFS to guide earlier individualized treatment decisions, including adjuvant therapy and intensified surveillance, in stage IA NSCLC.
L. Lai, Yanji Wang, Jiangle Jiang et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
